Adamas Pharmaceuticals Stock – NasdaqGM: ADMS

Adamas Pharmaceuticals Stock – Kehoe Law Firm, P.C. Investigating Breach of Fiduciary Duty Claims on Behalf of ADMS Investors – ADMS Shareholders Encouraged to Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating breach of fiduciary duty claims on behalf of shareholders of Adamas Pharmaceuticals, Inc. (NasdaqGM: ADMS) that presently own the common stock of Adamas Pharmaceuticals, Inc.

On March 16, 2020, a verified shareholder derivative complaint was filed in United States District Court seeking to remedy alleged wrongdoing committed by Adamas Pharmaceuticals’ directors and officers from August 8, 2017 through September 30, 2019.

ADMS investors who currently own shares of Adamas Pharmaceuticals are encouraged to contact either Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], or John Kehoe, Esq, (215) 792-6676, Ext. 801, [email protected], to discuss the Adamas Pharmaceuticals investigation or potential legal claims.

Kehoe Law Firm, P.C.